Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renin-Angiotensin-Aldosterone System Modulates Blood Pressure Response During Vascular Endothelial Growth Factor Receptor Inhibition

Published:2019-09 Issue:1 Volume:1 Page:14-23
ISSN:2666-0873
Container-title:JACC: CardioOncology
language:en
Short-container-title:JACC: CardioOncology

Author:

Bottinor Wendy J.,Shuey Megan M.,Manouchehri Ali,Farber-Eger Eric H.,Xu Meng,Nair Devika,Salem Joe-Elie,Wang Thomas J.,Brittain Evan L.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Oncology

Reference36 articles.

1. Vascular and metabolic implications of novel targeted cancer therapies: focus on kinase inhibitors;Li;J Am Coll Cardiol,2015

2. Initial assessment, surveillance, and management of blood pressure in patients receiving vascular endothelial growth factor signaling pathway inhibitors;Maitland;J Natl Cancer Inst,2010

3. Cardiac side effects of molecular targeted therapies: towards a better dialogue between oncologists and cardiologists;Ederhy;Crit Rev Oncol Hematol,2011

4. Patient-reported outcomes of patients with advanced renal cell carincoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial;Cella;Lancet Oncol,2019

5. VEGF inhibition and renal thrombotic microangiopathy;Eremina;N Engl J Med,2008

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of new and emerging cancer drugs: what the cardiologist needs to know;European Heart Journal;2024-04-09

2. Management of arterial hypertension during therapy with antiangiogenic drugs in metastatic renal cell carcinoma;Medical alphabet;2023-10-23

3. Vasotoxic Effects of Anticancer Therapy: a Review of Current Data;Rational Pharmacotherapy in Cardiology;2023-05-12

4. Smooth Muscle Mineralocorticoid Receptor Promotes Hypertension After Preeclampsia;Circulation Research;2023-03-17

5. Anti-cancer agents and drug-induced hypertension;Medical alphabet;2022-09-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3